Blog

This morning, Johnson & Johnson shared its 2025 third-quarter earnings report.

Since its founding in 1886, the company has been committed to innovation—today, more than 138,000 employees across the globe work to deliver solutions for patients around the world and to help profoundly impact health for humanity.

“Building on the momentum of the first half of the year, we delivered strong third-quarter results,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Our performance was driven by addressing unmet needs in high-innovation, high-growth markets. The planned separation of our Orthopaedics business reflects another step in the evolution of our portfolio, and we are confident that business will be better positioned for long-term success. As we look ahead, our portfolio strength and pipeline progression enables our ability to deliver accelerated growth through the remainder of the decade.”

For more details about the company’s 2025 third-quarter results and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.